We are live on ! Find out more
Banque Cantonale Vaudoise

Banque Cantonale Vaudoise Portfolio holdings

AUM $722M Turnover 23.22%
1-Year Est. Return 30.45%
This Fund
S&P 500
This Quarter Est. Return
+16.26%
1 Year Est. Return
+30.45%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$722M
AUM Growth
-$1.94B
Cap. Flow
-$438M
Cap. Flow %
-60.67%
Top 10 Hldgs %
58.22%
Holding
956
New
82
Increased
260
Reduced
372
Closed
140
Avg Time Held
3.3 years
Top 10 Avg Time Held
1 year
Top 20 Avg Time Held
0.9 years

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$21.9M
2
AZN icon
AstraZeneca
AZN
+$11.4M
3
AMRZ icon
Amrize Ltd
AMRZ
+$10.6M
4
JNJ icon
Johnson & Johnson
JNJ
+$8.1M
5
WMT icon
Walmart Inc
WMT
+$5.76M

Sector Composition

Rank Sector Weight
1 Technology 23.44%
2 Healthcare 20.15%
3 Communication Services 15.97%
4 Industrials 10.45%
5 Materials 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SPGI icon
251
S&P Global
SPGI
$133B
$5.55K ﹤0.01%
13,626
-2,262
-14% -$955K
2019 Q4
26 quarters
MDT icon
252
Medtronic
MDT
$122B
$5.52K ﹤0.01%
70,513
+2,897
+4% +$234K
2019 Q4
26 quarters
FFIV icon
253
F5
FFIV
$25.8B
$5.34K ﹤0.01%
12,833
-1,534
-11% -$545K
2019 Q4
26 quarters
PGR icon
254
Progressive
PGR
$132B
$5.27K ﹤0.01%
24,109
-7,800
-24% -$1.57M
2019 Q4
26 quarters
TMO icon
255
Thermo Fisher Scientific
TMO
$249B
$5.12K ﹤0.01%
10,203
-915
-8% -$439K
2019 Q4
26 quarters
NU icon
256
Nu Holdings
NU
$73.2B
$5.01K ﹤0.01%
375,230
+5,621
+2% +$75.8K
2024 Q2
8 quarters
VRTX icon
257
Vertex Pharmaceuticals
VRTX
$133B
$4.98K ﹤0.01%
10,020
+1,093
+12% +$484K
2019 Q4
26 quarters
LOW icon
258
Lowe's Companies
LOW
$111B
$4.98K ﹤0.01%
22,570
-10,105
-31% -$2.29M
2019 Q4
26 quarters
MCK icon
259
McKesson
MCK
$117B
$4.92K ﹤0.01%
6,511
-94
-1% -$74.5K
2019 Q4
26 quarters
ZTS icon
260
Zoetis
ZTS
$33.5B
$4.79K ﹤0.01%
66,623
+14,688
+28% +$1.38M
2019 Q4
26 quarters
GLD icon
261
SPDR Gold Trust
GLD
$135B
$4.77K ﹤0.01%
12,943
-267
-2% -$111K
2019 Q4
26 quarters
OKTA icon
262
Okta
OKTA
$37.2B
$4.7K ﹤0.01%
34,480
+1,724
+5% +$162K
2019 Q4
26 quarters
JCI icon
263
Johnson Controls International
JCI
$87.2B
$4.59K ﹤0.01%
31,416
-3,577
-10% -$505K
2019 Q4
26 quarters
TER icon
264
Teradyne
TER
$48.3B
$4.56K ﹤0.01%
9,421
+4,320
+85% +$1.63M
2025 Q4
2 quarters
O icon
265
Realty Income
O
$53.8B
$4.44K ﹤0.01%
71,653
+49,636
+225% +$3.09M
2026 Q1
1 quarter
RBRK icon
266
Rubrik
RBRK
$26.7B
$4.4K ﹤0.01%
54,751
+8,015
+17% +$504K
2025 Q3
3 quarters
ORLY icon
267
O'Reilly Automotive
ORLY
$72.7B
$4.36K ﹤0.01%
47,336
+4,643
+11% +$424K
2024 Q1
9 quarters
HPE icon
268
Hewlett Packard
HPE
$75.3B
$4.36K ﹤0.01%
96,594
+14,396
+18% +$520K
2019 Q4
26 quarters
YUM icon
269
Yum! Brands
YUM
$40.9B
$4.34K ﹤0.01%
27,161
+11,927
+78% +$1.85M
2019 Q4
26 quarters
AIRR icon
270
First Trust RBA American Industrial Renaissance ETF
AIRR
$8.31B
$4.25K ﹤0.01%
31,860
+485
+2% +$61.2K
2025 Q1
5 quarters
IAU icon
271
iShares Gold Trust
IAU
$59.3B
$4.11K ﹤0.01%
54,486
+200
+0.4% +$17K
2019 Q4
26 quarters
IDXX icon
272
Idexx Laboratories
IDXX
$44.1B
$4.09K ﹤0.01%
7,761
-1,452
-16% -$814K
2019 Q4
26 quarters
NBIS icon
273
Nebius Group N.V.
NBIS
$43.2B
$4.08K ﹤0.01%
14,760
+14,336
+3,381% +$2.84M
2021 Q1
21 quarters
KDP icon
274
Keurig Dr Pepper
KDP
$47.2B
$4.04K ﹤0.01%
123,515
+8,957
+8% +$261K
2019 Q4
26 quarters
KEYS icon
275
Keysight
KEYS
$53.6B
$4.03K ﹤0.01%
11,501
+8,693
+310% +$2.96M
2025 Q4
2 quarters

Similar funds

Banque Cantonale Vaudoise's Q2 2026 Portfolio in Review

As of Q2 2026, Banque Cantonale Vaudoise held 956 positions worth $722M, down 73% from $2.66B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Banque Cantonale Vaudoise withdrew a net $438M in Q2 2026, closing 140 positions and reducing 372 holdings. Its most notable exit was Apple, an estimated $85.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 28% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Banque Cantonale Vaudoise opened a new position in AstraZeneca worth $11.3M.

  • Banque Cantonale Vaudoise's largest Q2 2026 buy was AstraZeneca: 60,462 shares worth $11.3M.
  • Banque Cantonale Vaudoise added most to Microsoft in Q2 2026, an estimated $21.9M increase.
  • Banque Cantonale Vaudoise's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $14.3M.
  • Banque Cantonale Vaudoise fully exited Apple in Q2 2026, selling an estimated $85.9M.
  • Banque Cantonale Vaudoise's ten largest holdings make up 58% of its $722M portfolio in Q2 2026.
  • Banque Cantonale Vaudoise opened 82 new positions and closed 140 in Q2 2026.
  • Banque Cantonale Vaudoise's portfolio value fell 73% quarter-over-quarter to $722M.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.